Trilaciclib Dihydrochloride | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Trilaciclib Dihydrochloride
US Patents

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

With Fermion, start the journey of your innovative API.

Contact Supplier

Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Trilaciclib Dihydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

2 API Suppliers, 1 USDMF, 7 NDC API, 1 Listed Suppliers

2 API Suppliers
1 USDMF
7 NDC API
1 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

1 FDF Dossiers, 1 FDA Orange Book

1 FDF Dossiers
1 FDA Orange Book

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow

1 DATA COMPILATION #PharmaFlow

PATENTS & EXCLUSIVITIES

15 US Patents, 1 US Exclusivities

15 US Patents
1 US Exclusivities

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

15 All

01 15PHARMACOSMOS

filter Patent Number Reset all filters

15 All

01 18598186

02 18598197

03 29487530

04 19957276

05 110085992

06 110189849

07 110189850

08 110927120

09 210966984

10 111040042

11 111529352

12 211717523

filter API Patent Reset all filters

15 All

01 4Y

02 11Blank

filter FDF Patent Reset all filters

15 All

01 5Y

02 10Blank

filter Expiration Date Reset all filters

15 All

01 72031-10-25

02 72034-03-14

03 12039-07-23

Product Main Page

01

PHARMACOSMOS

TRILACICLIB DIHYDROCHLORIDE

Antibody Engineering

Not Confirmed

PHARMACOSMOS

Country

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-03-14

TRILACICLIB DIHYDROCHLORIDE

US Patent Number : 9487530

Drug Substance Claim :

Drug Product Claim :

Application Number : 214200

Patent Use Code : U-3079

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-03-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

PHARMACOSMOS

TRILACICLIB DIHYDROCHLORIDE

Antibody Engineering

Not Confirmed

PHARMACOSMOS

Country

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-03-14

TRILACICLIB DIHYDROCHLORIDE

US Patent Number : 9487530

Drug Substance Claim :

Drug Product Claim :

Application Number : 214200

Patent Use Code : U-3080

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-03-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

PHARMACOSMOS

TRILACICLIB DIHYDROCHLORIDE

Antibody Engineering

Not Confirmed

PHARMACOSMOS

Country

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-03-14

TRILACICLIB DIHYDROCHLORIDE

US Patent Number : 10085992

Drug Substance Claim :

Drug Product Claim :

Application Number : 214200

Patent Use Code : U-3081

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-03-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

PHARMACOSMOS

TRILACICLIB DIHYDROCHLORIDE

Antibody Engineering

Not Confirmed

PHARMACOSMOS

Country

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-07-23

TRILACICLIB DIHYDROCHLORIDE

US Patent Number : 11529352

Drug Substance Claim :

Drug Product Claim :

Application Number : 214200

Patent Use Code : U-3504

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-07-23

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

PHARMACOSMOS

TRILACICLIB DIHYDROCHLORIDE

Antibody Engineering

Not Confirmed

PHARMACOSMOS

Country

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-03-14

TRILACICLIB DIHYDROCHLORIDE

US Patent Number : 11717523

Drug Substance Claim :

Drug Product Claim :

Application Number : 214200

Patent Use Code : U-3678

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-03-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

PHARMACOSMOS

TRILACICLIB DIHYDROCHLORIDE

Antibody Engineering

Not Confirmed

PHARMACOSMOS

Country

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-03-14

TRILACICLIB DIHYDROCHLORIDE

US Patent Number : 11717523

Drug Substance Claim :

Drug Product Claim :

Application Number : 214200

Patent Use Code : U-3679

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-03-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

PHARMACOSMOS

TRILACICLIB DIHYDROCHLORIDE

Antibody Engineering

Not Confirmed

PHARMACOSMOS

Country

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-03-14

TRILACICLIB DIHYDROCHLORIDE

US Patent Number : 10966984

Drug Substance Claim :

Drug Product Claim :

Application Number : 214200

Patent Use Code : U-3079

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-03-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

PHARMACOSMOS

TRILACICLIB DIHYDROCHLORIDE

Antibody Engineering

Not Confirmed

PHARMACOSMOS

Country

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-03-14

TRILACICLIB DIHYDROCHLORIDE

US Patent Number : 10966984

Drug Substance Claim :

Drug Product Claim :

Application Number : 214200

Patent Use Code : U-3080

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-03-14

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

09

PHARMACOSMOS

TRILACICLIB DIHYDROCHLORIDE

Antibody Engineering

Not Confirmed

PHARMACOSMOS

Country

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-10-25

TRILACICLIB DIHYDROCHLORIDE

US Patent Number : 11040042

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214200

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-10-25

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

10

PHARMACOSMOS

TRILACICLIB DIHYDROCHLORIDE

Antibody Engineering

Not Confirmed

PHARMACOSMOS

Country

Antibody Engineering

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-10-25

TRILACICLIB DIHYDROCHLORIDE

US Patent Number : 10189850

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 214200

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2031-10-25

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?